APOTECAchemo manages
Drugs in bottles up to 100 ml, elastomeric pumps, bags up to 1000 ml, syringes 5, 20, 50 ml
Interface with standard HL7 protocols
Warehouse Area
Carousel, vision system for drug recognition, barcode reader
Preparation Area
6-axis robot, high precision scale, powder drugs mixer
Air treatment system
5 input HEPA filters and 1 output HEPA filter
Special waste collection unit
Interchangeable rigid trash automatically sealed
User interface
Touch screen
Size
Height 7’10’’, width 6’10’’, depth 5’3’’ (Including ventilation)
Electrical requirments
Supply type: 3P+PE
Connection Type grounding TT, TN, EN
Input voltage (configurable at installation):
400 VAC ±10%
440 VAC ±10%
480 VAC -10%, +0%
Frequency: 50/60 Hz
Electrical power consumption: 5kW
Compliance
EMC Class A (according to IEC 61326-1)
ISO 5 (according to ISO 14644)
Environment requires the same GMP standards as a laminar flow cabinet.
Once accuracy and sterility concerns were mastered, our attention turned to optimizing throughput without sacrificing accuracy and sterility. With years of prototyping and experimentation, we have applied a series of hardware and software changes to advance the performance in every key measurement area. APOTECAchemo is the only chemotherapy robot in the world with these proprietary design advances. The results have been profound.
New management of the loading worklists, new carousel placements, new software platform, structural changes and carefully defined robotic arm routes, greatly improves the speed and performance of APOTECAchemo. This is the safest, fastest, chemotherapy
automation system we have ever produced.
In every system the dialogue among the parties helps ensure efficiency and safety. With APOTECAchemo, pieces of information guide the patient’s cancer therapy: the oncologist prescribes, the pharmacist monitors, the technician performs the instructions of APOTECAchemo and the drug is returned to the nurses to be administered to the patient.
Security and integrity of information and auditability ensures maximum control. The module for managing the process of drug preparation can be interfaced with the oncology/ pharmacy computer systems. APOTECAchemo automatically receives orders and begins to process them once they have been validated by the pharmacist. The patient receives a chemotherapy preparation for which quality is assured.
Drug utilization may be optimized automatically as APOTECAchemo scrutinizes the order list and parking lot.
The clinical validation of APOTECAchemo was made through rigorous protocols including the monitoring and measuring of:
The numerous validation tests carried out using controlled protocols in hospital pharmacies showed a total integration of APOTECAchemo into the operational processes
In the oncology pharmacy, each admixture is tailored for the individual patient based on the physician’s orders, real-time lab results and input from the pharmacy team.
The challenge is to prepare sterile, accurate chemotherapy doses for a specific patient, based on real-time information while the patient is waiting at the facility. Complicating the effort are the pressures of modern healthcare, including the high cost of the medications, the importance of timely, accurate information and the hazardous nature of compounds. This makes ma nual preparations complex and difficult.
Comprehensive technology must be part of the solution. Borrowing and building on proven technology from other industries, applying worldwide best practices for safe compounding and combining a system-based emphasis on the importance of measures is the winning formula.
The automated compounding process is an integral part of a patient-centered system where coordinating materials, data and activities works in synergy with the objective of maximum efficiency and risk reduction.
The technology becomes a tool to serve a higher purpose: to benefit the people involved, patients, family members and health care workers. APOTECAchemo delivers measureable, meaningful value across many dimensions including patient safety, operator safety, pharmacist efficiency, physician satisfaction, nursing confidence, inventory management, cost reduction, automated record keeping, and risk management.
Currently managed disposables that have been tested and used:
- medicines in bottles up to 100 ml
- elastomeric pumps
- bags up to 1000 ml
- syringes of 5, 20, 50 ml
Medications currently administered:
- 52 active ingredients, others in testing
- 164 bottles
- lyophilised
- ready solutions
Spectrum of drug*
*Updated at February 2011
Productivity with advanced multi-tasking operations:
- prepared solution in single medication syringe 100 seconds
- prepared solution in single medication IV bag 145 seconds
